p53 and Rb proteins can be used as markers of NECs in all sites, while the lack of DAXX and ATRX mutations in NENs subsets other than pancreatic NENs limits the use of the complete approach to this type of tumor only [57]. The gene discussed is ATRX; the disease is neoplasm.